Upload Image (Max 20MB per Image)
Boehringer Ingelheim and Funxional Therapeutics have signed an agreement under which Boehringer will acquire the global rights to Funxional's FX125L compound and somatotaxin program. Boehringer is responsible for all further research, ...
Tags: Boehringer Ingelheim, Funxional Therapeutics, acquire